All US holdings of this investor are reported in this report. Top holdings included OPKO HEALTH INC, ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, INTERCEPT PHARMACEUTICALS IN, and EVENTBRITE INC.
PenderFund Capital Management Ltd. Q4 2022 Portfolio
Our algorithm has found invalid data in this filing
Sym
Weight
Trade Impact
Company
Class
Share Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
Filing 2022 Q4 compared to 2022 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Gina Jones
CFO, CCO
Vancouver, British Columbia, Canada
10 Feb 2023
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.